Pages that link to "Q44440416"
Jump to navigation
Jump to search
The following pages link to Alterations in lipid kinetics in men with HIV-dyslipidemia. (Q44440416):
Displaying 45 items.
- Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy (Q25255216) (← links)
- HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation (Q33562238) (← links)
- Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis (Q34312147) (← links)
- Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function. (Q34512603) (← links)
- Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment. (Q34564973) (← links)
- HIV protease inhibitors and obesity (Q34792983) (← links)
- Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial (Q35101789) (← links)
- Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease (Q35104006) (← links)
- Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution (Q35176441) (← links)
- Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia (Q35384143) (← links)
- The Pathophysiology of HIV-/HAART-Related Metabolic Syndrome Leading to Cardiovascular Disorders: The Emerging Role of Adipokines (Q35607320) (← links)
- Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy (Q35739799) (← links)
- Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments (Q35747264) (← links)
- Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr (Q35834850) (← links)
- A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy (Q35899038) (← links)
- Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study. (Q35927192) (← links)
- The Effects of HIV Protease Inhibitors on Carbohydrate and Lipid Metabolism (Q38636036) (← links)
- Body Composition and Metabolic Changes in HIV-Infected Patients (Q38639965) (← links)
- Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors. (Q36011828) (← links)
- Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis (Q36145648) (← links)
- Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin (Q36367336) (← links)
- HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk (Q36773367) (← links)
- Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy (Q36914988) (← links)
- Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. (Q36951647) (← links)
- HIV-associated dyslipidaemia: pathogenesis and treatment (Q37018213) (← links)
- Metabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative? (Q37153502) (← links)
- Treatment of dyslipidemia in HIV-infected patients (Q37756963) (← links)
- Treatment of dyslipidemia in HIV. (Q38363531) (← links)
- HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies. (Q38855423) (← links)
- Biochemical Manifestation of HIV Lipodystrophy Syndrome (Q38953001) (← links)
- Adipose Tissue in HIV Infection (Q40038736) (← links)
- Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics (Q40239178) (← links)
- HIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity (Q40314379) (← links)
- Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir (Q42176233) (← links)
- Prevalence of Hyperapolipoprotein B and Associations with Other Cardiovascular Risk Factors Among Human Immunodeficiency Virus–Infected Patients in Pernambuco, Brazil (Q42861251) (← links)
- Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study (Q42910393) (← links)
- Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome (Q44581816) (← links)
- Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men. (Q45990511) (← links)
- Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. (Q46665887) (← links)
- Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia (Q51535624) (← links)
- Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice (Q57691255) (← links)
- Adipose Tissue in Persons With HIV Is Enriched for CD4 T Effector Memory and T Effector Memory RA Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance (Q64075211) (← links)
- The effects of HIV protease inhibitors on carbohydrate and lipid metabolism (Q81037654) (← links)
- Obesity and Weight Gain in Persons with HIV (Q89771713) (← links)
- Inflammation and Metabolic Complications in HIV (Q90602763) (← links)